News and Press releases

30.3.2016

Medsenic SAS, a biopharmaceutical company dedicated to the treatment of autoimmune diseases with arsenic derivatives, announced today that it raised funds from two investment actors, Alsace Capital (Cap Innov’Est) and Fa Dièse (Fa Dièse 3). The CNRS (French Centre Nati...

Please reload

 

© 2018 FADiese